StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

Stereotaxis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Stereotaxis's price to sales ratio was 2.9× on Nov 11, 2026, against 7.3× a year earlier. Over the last 5 years it ranged from 2.8× to 13.9×, with a median of 5.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×−3.9
2025Dec 31, 20256.8×−0.9
2024Dec 31, 20247.6×+2.9
2023Dec 29, 20234.7×−0.7
2022Dec 30, 20225.4×−8.5
2021Dec 31, 202113.9×+0.4
2020Dec 31, 202013.5×+2.6
2019Dec 31, 201911.0×+9.4
2018Dec 31, 20181.6×+1.0
2017Dec 29, 20170.6×+0.2
2016Dec 30, 20160.4×+0.0
2015Dec 31, 20150.4×−0.4
2014Dec 31, 20140.8×−0.6
2013Dec 31, 20131.4×+0.9
2012Dec 31, 20120.5×–

More Stereotaxis figures

See a number that looks wrong?